Lanreotide acetate CAS NO 127984-74-1 Inquire about Lanreotide acetate 

Tecoland supplies Lanreotide acetate bulk active pharmaceutical ingredient (API) to the pharmaceutical industry. Our Lanreotide acetate is manufactured by cGMP compliant facility. Welcome to contact us for further details including current DMF status for the product and up to date regulatory status of the manufacturing facility. We look forward to assisting you with your research and development projects.
What is Lanreotide?Lanreotide acetate

Lanreotide lowers many substances in the body such as insulin and glucagon (involved in regulating blood sugar), growth hormone, and chemicals that affect digestion.

Lanreotide is used in adults to treat:

  • acromegaly that cannot be treated with surgery or radiation;
  • carcinoid syndrome; or
  • a certain type of pancreatic or digestive tract tumor that may spread to other parts of the body.

Lanreotide is sometimes given after other treatments have failed.

Lanreotide may also be used for purposes not listed in this medication guide.

Important Information

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

Before taking this medicine

You should not use lanreotide if you are allergic to it.

Tell your doctor if you have ever had:

  • gallbladder disease;
  • diabetes (your diabetes medicine may need to be adjusted);
  • liver or kidney disease;
  • heart disease; or
  • a thyroid disorder.

It is not known whether lanreotide will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

This medicine may affect fertility (your ability to have children) in women.

You should not breast-feed while using lanreotide and for at least 6 months after your last dose.

How is lanreotide given?

Lanreotide is injected under the skin.

A healthcare provider will give you this injection.

Lanreotide is usually given once every 4 weeks. Your doctor may occasionally change how often you receive injections.

Call your doctor if your symptoms do not improve, or if they get worse.

Your blood sugar may need to be checked often, and you may need other blood tests at your doctor’s office.

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your lanreotide injection.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using lanreotide?

Follow your doctor’s instructions about any restrictions on food, beverages, or activity.

Lanreotide side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • chest pain, slow heartbeats;
  • shortness of breath;
  • a light-headed feeling, like you might pass out;
  • confusion, memory problems;
  • feeling very weak or tired;
  • a light-headed feeling, like you might pass out;
  • low blood sugar–headache, hunger, sweating, irritability, dizziness, fast heart rate, and feeling anxious or shaky;
  • high blood sugar–increased thirst, increased urination, dry mouth, fruity breath odor;
  • underactive thyroid symptoms–tiredness, depressed mood, dry skin, thinning hair, decreased sweating, weight gain, puffiness in your face, feeling more sensitive to cold temperatures; or
  • signs of a gallbladder problem–sudden severe pain in your upper stomach spreading to your back or shoulder (may occur after meals or at night), nausea, fever, chills, yellowing of the skin or eyes.

Common side effects may include:

  • headache, pounding in your neck or ears;
  • dizziness;
  • nausea, vomiting, diarrhea, stomach pain;
  • muscle or joint pain;
  • headache, dizziness; or
  • pain, itching, or a hard lump where the medicine was injected.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Lanreotide dosing information

Usual Adult Dose for Acromegaly:

Initial dose: 90 mg, by deep subcutaneous injection, every 4 weeks for 3 months

Comments:
-The goal of treatment is to reduce growth hormone (GH) and insulin-like growth factor (IGF-1) levels to normal.
-Adjust dose after initial 3 months.
-No dose adjustment is required for elderly patients.

Use: Long-term treatment of acromegalic patients who have had an inadequate response to surgery and/or radiotherapy, or for whom surgery and/or radiotherapy is not an option.

Usual Adult Dose for Neuroendocrine Carcinoma:

120 mg, by deep subcutaneous injection, every 4 weeks

Comments: No dose adjustment is required for elderly patients.

Use: Treatment of patients with unresectable, well or moderately-differentiated, locally advanced, or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) to improve progression-free survival.

Usual Adult Dose for Carcinoid Syndrome:

120 mg by deep subcutaneous injection every 4 weeks

Comments: If patients are already being treated for GEP-NETs, do not administer an additional dose for the treatment of carcinoid syndrome.

Use: For the treatment of carcinoid syndrome; when used, it reduces the frequency of short-acting somatostatin analog rescue therapy.

What other drugs will affect lanreotide?

When you start or stop taking lanreotide, your doctor may need to adjust the doses of any other medicines you take on a regular basis.

Tell your doctor about all your other medicines, especially:

  • bromocriptine;
  • cyclosporine;
  • insulin or oral diabetes medicine; or
  • beta-blocker heart or blood pressure medicine (such as atenolol, carvedilol, metoprolol, propranolol, sotalol, and others).

This list is not complete. Other drugs may affect lanreotide, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer:

Information on this page is provided for general information purposes. You should not make a clinical treatment decision based on information contained in this page without consulting other references including the package insert of the drug, textbooks and where relevant, expert opinion. We cannot be held responsible for any errors you make in administering drugs mentioned on this page, nor for use of any erroneous information contained on this page.

External Link:

Lanreotide. (n.d.). Drugs.Com. https://www.drugs.com/mtm/lanreotide.html